News from the FDA/CDC

Adult diabetes up 35% over 25 years


 

The overall prevalence of diabetes increased 35% from 1988-1994 to 2011-2014 among adults aged 20 years and over, according the National Center for Health Statistics.

During 2011-2014, the age-adjusted prevalence of diabetes was 11.9% in adults aged 20 years and over, compared with 8.8% in 1988-1994. That 35% increase came despite a decrease in undiagnosed diabetes from 3.6% to 2.9% over that time period, which was not enough to offset a jump in physician-diagnosed disease from 5.2% to 9%, the NCHS reported in “Health, United States, 2016.”

Diabetes prevalence among adults aged 20 years and over
Although diabetes prevalence was up for each of the largest racial/ethnic groups, only the increase from 7.7% to 9.6% in non-Hispanic whites was statistically significant. Prevalence in non-Hispanic blacks rose from 16.3% to 18% from 1988-1994 to 2011-2014, and adults of Mexican origin saw an increase from 15.6% to 18%. Neither change was statistically significant, the NCHS said.

Undiagnosed diabetes dropped from 2.9% to 2% in whites and from 7.2% to 4.6% in blacks, but adults of Mexican origin saw a slight increase from 5% in 1988-1994 to 5.1% in 2011-2014. The physician-diagnosed side of the equation rose from 4.8% to 7.6% in whites, 9.1% to 13.4% in blacks, and 10.7% to 13% in those of Mexican origin, according to data from the National Health and Nutrition Examination Survey, which combines interviews and physical examinations, including laboratory analysis of blood samples.

Recommended Reading

IDegLira equals basal-bolus insulin in HbA1c, lowers hypoglycemia risk
MDedge Internal Medicine
ODYSSEY: Alirocumab improves lipids but not glycemic targets in 2DM
MDedge Internal Medicine
DURATION-8: Exenatide/dapagliflozin efficacy holds up at 1 year
MDedge Internal Medicine
SPRINT: Intensive BP control cut cardiovascular risk in patients with prediabetes
MDedge Internal Medicine
FDA advisory committee supports new CV liraglutide indication
MDedge Internal Medicine
Oral insulin matches glargine in phase II trial
MDedge Internal Medicine
Nocturia and sleep apnea
MDedge Internal Medicine
LEADER post hoc analysis: Mechanism behind liraglutide’s cardioprotective effects unclear
MDedge Internal Medicine
Red flags for type 2 diabetes seen 25 years before diagnosis
MDedge Internal Medicine
Insulin degludec decreases rate, severity of hypoglycemic episodes
MDedge Internal Medicine

Related Articles